These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36368887)

  • 1. IQOS and cigarette advertising across regulatory periods and population groups in Israel: a longitudinal analysis.
    Khayat A; Levine H; Berg CJ; Shauly-Aharonov M; Manor O; Abroms L; Romm KF; Wysota CN; Bar-Zeev Y
    Tob Control; 2024 Mar; 33(e1):e3-e10. PubMed ID: 36368887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PMI's IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups.
    Khayat A; Berg CJ; Levine H; Rodnay M; Abroms L; Romm KF; Duan Z; Bar-Zeev Y
    Tob Control; 2024 Mar; 33(e1):e54-e61. PubMed ID: 36418166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQOS news media coverage in Israel: a comparison across three subpopulations.
    Khayat A; Bar-Zeev Y; Kaufman Y; Berg C; Abroms L; Duan Z; LoParco CR; Wang Y; Cui Y; Levine H
    Tob Control; 2024 Jul; ():. PubMed ID: 39013604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IQOS: examination of Philip Morris International's claim of reduced exposure.
    St Helen G; Jacob Iii P; Nardone N; Benowitz NL
    Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.
    Berg CJ; Romm KF; Bar-Zeev Y; Abroms LC; Klinkhammer K; Wysota CN; Khayat A; Broniatowski DA; Levine H
    Tob Control; 2023 Jul; 32(4):418-427. PubMed ID: 34667105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel.
    Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y
    Res Sq; 2024 Mar; ():. PubMed ID: 38464035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.
    Bar-Zeev Y; Berg CJ; Abroms LC; Rodnay M; Elbaz D; Khayat A; Levine H
    Nicotine Tob Res; 2022 Jan; 24(1):100-108. PubMed ID: 34216461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of advertisements on smokers' interest in trying e-cigarettes: the roles of product comparison and visual cues.
    Pepper JK; Emery SL; Ribisl KM; Southwell BG; Brewer NT
    Tob Control; 2014 Jul; 23 Suppl 3(Suppl 3):iii31-6. PubMed ID: 24935896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.
    Glantz SA
    Tob Control; 2018 Nov; 27(Suppl 1):s9-s12. PubMed ID: 30131374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free-Base and Total Nicotine, Reactive Oxygen Species, and Carbonyl Emissions From IQOS, a Heated Tobacco Product.
    Salman R; Talih S; El-Hage R; Haddad C; Karaoghlanian N; El-Hellani A; Saliba NA; Shihadeh A
    Nicotine Tob Res; 2019 Aug; 21(9):1285-1288. PubMed ID: 30476301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heated tobacco products likely appeal to adolescents and young adults.
    McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
    Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
    Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low compliance and proliferation of IQOS purchase cues at points-of-sale: a comparative study before and after Israel's display ban.
    Bar-Zeev Y; Berg CJ; Khayat A; Abroms LC; Wang Y; Duan Z; LoParco CR; Cui Y; Elbaz D; Levine H
    Tob Control; 2024 Jun; ():. PubMed ID: 38862232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQOS
    Adriaens K; Gucht DV; Baeyens F
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30567400
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults.
    Berg CJ; Duan Z; Wang Y; Thrasher JF; Bar-Zeev Y; Abroms LC; Romm KF; Khayat A; Levine H
    Tob Control; 2024 Mar; 33(e1):e69-e77. PubMed ID: 36428095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between risk perceptions, anxiety, and self-reported changes in tobacco and nicotine product use due to COVID-19 in May-June 2020 in Israel.
    Rubinson NG; Fong GT; Gravely S; Quah ACK; Bitan M; Lev Ari S; Rosen LJ
    BMC Public Health; 2023 Apr; 23(1):759. PubMed ID: 37098558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS.
    Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H
    Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cigarette advertising exposure among South African adults in 2017: findings from a nationally representative cross-sectional survey.
    Agaku IT; Egbe CO; Ayo-Yusuf OA
    BMJ Open; 2021 Aug; 11(8):e048462. PubMed ID: 34400455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of IQOS risk perceptions on cigarette smoking behaviours: results from a prospective pilot study.
    DeAtley T; Stone MD; Strasser AA; Audrain-McGovern J
    Tob Control; 2024 Feb; 33(2):263-266. PubMed ID: 36002165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.